NCT06591910 2024-09-19Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung CancerShanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruiting50 enrolled